Skip to main content
Erschienen in: The journal of nutrition, health & aging 10/2017

02.11.2017

Cross-sectional associations of total plasma homocysteine with cortical β-amyloid independently and as a function of omega 3 polyunsaturated fatty acid status in older adults at risk of dementia

verfasst von: Claudie Hooper, P. de Souto Barreto, N. Coley, E. Caussé, P. Payoux, A. S. Salabert, M. Cesari, S. Andrieu, G.-L. Bowman, M. Weiner, B. Vellas, MAPT/DSA Study Group

Erschienen in: The journal of nutrition, health & aging | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Elevated total plasma homocysteine is a risk factor for Alzheimer’s disease (AD) and there is some evidence that omega-3 polyunsaturated fatty acids (n-3 PUFAs) can modulate the effects of homocysteine-lowering B vitamins on AD related pathologies. Hence we investigated the relationship between total plasma homocysteine and cortical β-amyloid (Aβ) in older adults at risk of dementia. The role of erythrocyte membrane n-3 PUFAs (omega 3 index) on this relationship was also explored.

Design

This is a cross-sectional study using data from the Multidomain Alzheimer Preventive Trial (MAPT); a randomised controlled trial.

Setting

French community dwellers aged 70 or over reporting subjective memory complaints, but free from a diagnosis of clinical dementia.

Participants

Individuals were from the MAPT trial (n = 177) with data on total plasma homocysteine at baseline and cortical Aβ load.

Measurements

Cortical-to-cerebellar standard uptake value ratios were assessed using [18F] florbetapir positron emission tomography (PET). Total baseline plasma homocysteine was measured using an enzymatic cycling assay. Baseline omega 3 index was measured using gas chromatography. Cross-sectional associations were explored using adjusted multiple linear regression models.

Results

We found that total baseline plasma homocysteine was not significantly associated with cortical Aβ as demonstrated using multiple linear regression models adjusted for age, sex, education, cognitive status, time interval between baseline and PET-scan, omega-3 index, MAPT group allocation and Apolipoprotein E ε4 status (B-coefficient -0.001, 95 % CI: -0.008,0.006, p = 0.838). Exploratory analysis showed that homocysteine was however significantly associated with cortical Aβ in subjects with low baseline omega-3 index (< 4.72 %) after adjustment for Apolipoprotein E ε4 status (B-coefficient 0.041, 95 % CI: 0.017,0.066, p = 0.005, n = 10), but not in subjects with a high baseline omega-3 index (B-coefficient -0.010, 95 % CI: -0.023,0.003, p = 0.132, n = 66).

Conclusions

The role of n-3 PUFAs on the relationship between homocysteine and cerebral Aβ warrants further investigation.
Literatur
1.
Zurück zum Zitat Smith AD, Refsum H. Homocysteine, B Vitamins, and Cognitive Impairment. Annu Rev Nutr. 2016 Jul 17;36:211–39.CrossRefPubMed Smith AD, Refsum H. Homocysteine, B Vitamins, and Cognitive Impairment. Annu Rev Nutr. 2016 Jul 17;36:211–39.CrossRefPubMed
2.
Zurück zum Zitat Oulhaj A, Refsum H, Beaumont H, Williams J, King E, Jacoby R, et al. Homocysteine as a predictor of cognitive decline in Alzheimer’s disease. Int J Geriatr Psychiatry. 2010 Jan;25(1):82–90.PubMed Oulhaj A, Refsum H, Beaumont H, Williams J, King E, Jacoby R, et al. Homocysteine as a predictor of cognitive decline in Alzheimer’s disease. Int J Geriatr Psychiatry. 2010 Jan;25(1):82–90.PubMed
3.
Zurück zum Zitat Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol. 2002 May;59(5):787–93.CrossRefPubMed Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol. 2002 May;59(5):787–93.CrossRefPubMed
4.
Zurück zum Zitat Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, et al. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol. 2002 Mar;51(3):285–9.CrossRefPubMed Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, et al. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol. 2002 Mar;51(3):285–9.CrossRefPubMed
5.
Zurück zum Zitat den Heijer T, Vermeer SE, Clarke R, Oudkerk M, Koudstaal PJ, Hofman A, et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain J Neurol. 2003 Jan;126(Pt 1):170–5.CrossRef den Heijer T, Vermeer SE, Clarke R, Oudkerk M, Koudstaal PJ, Hofman A, et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain J Neurol. 2003 Jan;126(Pt 1):170–5.CrossRef
6.
Zurück zum Zitat Sachdev PS, Valenzuela M, Wang XL, Looi JCL, Brodaty H. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology. 2002 May 28;58(10):1539–41.CrossRefPubMed Sachdev PS, Valenzuela M, Wang XL, Looi JCL, Brodaty H. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology. 2002 May 28;58(10):1539–41.CrossRefPubMed
7.
Zurück zum Zitat Hooshmand B, Polvikoski T, Kivipelto M, Tanskanen M, Myllykangas L, Erkinjuntti T, et al. Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study. Brain J Neurol. 2013 Sep;136(Pt 9):2707–16.CrossRef Hooshmand B, Polvikoski T, Kivipelto M, Tanskanen M, Myllykangas L, Erkinjuntti T, et al. Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study. Brain J Neurol. 2013 Sep;136(Pt 9):2707–16.CrossRef
8.
Zurück zum Zitat Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002 Feb 14;346(7):476–83.CrossRefPubMed Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002 Feb 14;346(7):476–83.CrossRefPubMed
9.
Zurück zum Zitat Zylberstein DE, Lissner L, Björkelund C, Mehlig K, Thelle DS, Gustafson D, et al. Midlife homocysteine and late-life dementia in women. A prospective population study. Neurobiol Aging. 2011 Mar;32(3):380–6.CrossRefPubMed Zylberstein DE, Lissner L, Björkelund C, Mehlig K, Thelle DS, Gustafson D, et al. Midlife homocysteine and late-life dementia in women. A prospective population study. Neurobiol Aging. 2011 Mar;32(3):380–6.CrossRefPubMed
10.
Zurück zum Zitat Zhuo J-M, Portugal GS, Kruger WD, Wang H, Gould TJ, Pratico D. Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer’s disease. Curr Alzheimer Res. 2010 Mar;7(2):140–9.CrossRefPubMedPubMedCentral Zhuo J-M, Portugal GS, Kruger WD, Wang H, Gould TJ, Pratico D. Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer’s disease. Curr Alzheimer Res. 2010 Mar;7(2):140–9.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Pacheco-Quinto J, Rodriguez de Turco EB, DeRosa S, Howard A, Cruz-Sanchez F, Sambamurti K, et al. Hyperhomocysteinemic Alzheimer’s mouse model of amyloidosis shows increased brain amyloid beta peptide levels. Neurobiol Dis. 2006 Jun;22(3):651–6.CrossRefPubMed Pacheco-Quinto J, Rodriguez de Turco EB, DeRosa S, Howard A, Cruz-Sanchez F, Sambamurti K, et al. Hyperhomocysteinemic Alzheimer’s mouse model of amyloidosis shows increased brain amyloid beta peptide levels. Neurobiol Dis. 2006 Jun;22(3):651–6.CrossRefPubMed
12.
Zurück zum Zitat Zhang C-E, Wei W, Liu Y-H, Peng J-H, Tian Q, Liu G-P, et al. Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gammasecretase and phosphorylation of amyloid precursor protein in rat brain. Am J Pathol. 2009 Apr;174(4):1481–91.CrossRefPubMedPubMedCentral Zhang C-E, Wei W, Liu Y-H, Peng J-H, Tian Q, Liu G-P, et al. Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gammasecretase and phosphorylation of amyloid precursor protein in rat brain. Am J Pathol. 2009 Apr;174(4):1481–91.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Popp J, Lewczuk P, Linnebank M, Cvetanovska G, Smulders Y, Kölsch H, et al. Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer’s disease. J Alzheimers Dis JAD. 2009;18(4):819–28.CrossRefPubMed Popp J, Lewczuk P, Linnebank M, Cvetanovska G, Smulders Y, Kölsch H, et al. Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer’s disease. J Alzheimers Dis JAD. 2009;18(4):819–28.CrossRefPubMed
14.
Zurück zum Zitat Luchsinger JA, Tang M-X, Miller J, Green R, Mehta PD, Mayeux R. Relation of plasma homocysteine to plasma amyloid beta levels. Neurochem Res. 2007 May;32(4–5):775–81.CrossRefPubMed Luchsinger JA, Tang M-X, Miller J, Green R, Mehta PD, Mayeux R. Relation of plasma homocysteine to plasma amyloid beta levels. Neurochem Res. 2007 May;32(4–5):775–81.CrossRefPubMed
15.
Zurück zum Zitat Irizarry MC, Gurol ME, Raju S, Diaz-Arrastia R, Locascio JJ, Tennis M, et al. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology. 2005 Nov 8;65(9):1402–8.CrossRefPubMed Irizarry MC, Gurol ME, Raju S, Diaz-Arrastia R, Locascio JJ, Tennis M, et al. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology. 2005 Nov 8;65(9):1402–8.CrossRefPubMed
16.
Zurück zum Zitat Oikonomidi A, Lewczuk P, Kornhuber J, Smulders Y, Linnebank M, Semmler A, et al. Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta. J Neurochem. 2016 Oct;139(2):324–32.CrossRefPubMed Oikonomidi A, Lewczuk P, Kornhuber J, Smulders Y, Linnebank M, Semmler A, et al. Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta. J Neurochem. 2016 Oct;139(2):324–32.CrossRefPubMed
17.
Zurück zum Zitat Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, et al. A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study. Mol Psychiatry. 2014 Apr;19(4):519–26.CrossRefPubMed Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, et al. A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study. Mol Psychiatry. 2014 Apr;19(4):519–26.CrossRefPubMed
18.
Zurück zum Zitat Huang T, Zheng J, Chen Y, Yang B, Wahlqvist ML, Li D. High consumption of Ω-3 polyunsaturated fatty acids decrease plasma homocysteine: a meta-analysis of randomized, placebo-controlled trials. Nutr Burbank Los Angel Cty Calif. 2011 Sep;27(9):863–7.CrossRef Huang T, Zheng J, Chen Y, Yang B, Wahlqvist ML, Li D. High consumption of Ω-3 polyunsaturated fatty acids decrease plasma homocysteine: a meta-analysis of randomized, placebo-controlled trials. Nutr Burbank Los Angel Cty Calif. 2011 Sep;27(9):863–7.CrossRef
19.
Zurück zum Zitat Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215–21.CrossRefPubMed Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215–21.CrossRefPubMed
20.
Zurück zum Zitat Oulhaj A, Jernerén F, Refsum H, Smith AD, de Jager CA. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. J Alzheimers Dis JAD. 2016;50(2):547–57.CrossRefPubMed Oulhaj A, Jernerén F, Refsum H, Smith AD, de Jager CA. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. J Alzheimers Dis JAD. 2016;50(2):547–57.CrossRefPubMed
21.
Zurück zum Zitat Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol Sci. 1991 Oct;12(10):383–8.CrossRefPubMed Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol Sci. 1991 Oct;12(10):383–8.CrossRefPubMed
22.
Zurück zum Zitat Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 1992 Apr 10;256(5054):184–5.CrossRefPubMed Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 1992 Apr 10;256(5054):184–5.CrossRefPubMed
23.
Zurück zum Zitat Vellas B, Carrie I, Gillette-Guyonnet S, Touchon J, Dantoine T, Dartigues JF, et al. MAPT study: A multidomain approach for preventing Alzheimer’s DISEASE: DESIGN AND BASELINE DATA. J Prev Alzheimers Dis. 2014 Jun;1(1):13–22.PubMedPubMedCentral Vellas B, Carrie I, Gillette-Guyonnet S, Touchon J, Dantoine T, Dartigues JF, et al. MAPT study: A multidomain approach for preventing Alzheimer’s DISEASE: DESIGN AND BASELINE DATA. J Prev Alzheimers Dis. 2014 Jun;1(1):13–22.PubMedPubMedCentral
24.
Zurück zum Zitat Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017 Mar 27 Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017 Mar 27
25.
Zurück zum Zitat Del Campo N, Payoux P, Djilali A, Delrieu J, Hoogendijk EO, Rolland Y, et al. Relationship of regional brain β-amyloid to gait speed. Neurology. 2016 Jan 5;86(1):36–43.CrossRefPubMedPubMedCentral Del Campo N, Payoux P, Djilali A, Delrieu J, Hoogendijk EO, Rolland Y, et al. Relationship of regional brain β-amyloid to gait speed. Neurology. 2016 Jan 5;86(1):36–43.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Joshi AD, Pontecorvo MJ, Clark CM, Carpenter AP, Jennings DL, Sadowsky CH, et al. Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer’s disease and cognitively normal subjects. J Nucl Med Off Publ Soc Nucl Med. 2012 Mar;53(3):378–84. Joshi AD, Pontecorvo MJ, Clark CM, Carpenter AP, Jennings DL, Sadowsky CH, et al. Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer’s disease and cognitively normal subjects. J Nucl Med Off Publ Soc Nucl Med. 2012 Mar;53(3):378–84.
27.
Zurück zum Zitat Dou C, Xia D, Zhang L, Chen X, Flores P, Datta A, et al. Development of a novel enzymatic cycling assay for total homocysteine. Clin Chem. 2005 Oct;51(10):1987–9.CrossRefPubMed Dou C, Xia D, Zhang L, Chen X, Flores P, Datta A, et al. Development of a novel enzymatic cycling assay for total homocysteine. Clin Chem. 2005 Oct;51(10):1987–9.CrossRefPubMed
28.
Zurück zum Zitat Legrand P, Schmitt B, Mourot J, Catheline D, Chesneau G, Mireaux M, et al. The consumption of food products from linseed-fed animals maintains erythrocyte omega- 3 fatty acids in obese humans. Lipids. 2010 Jan;45(1):11–9.CrossRefPubMed Legrand P, Schmitt B, Mourot J, Catheline D, Chesneau G, Mireaux M, et al. The consumption of food products from linseed-fed animals maintains erythrocyte omega- 3 fatty acids in obese humans. Lipids. 2010 Jan;45(1):11–9.CrossRefPubMed
29.
Zurück zum Zitat Alzheimer’s Association. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement J Alzheimers Assoc. 2016 Apr;12(4):459–509.CrossRef Alzheimer’s Association. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement J Alzheimers Assoc. 2016 Apr;12(4):459–509.CrossRef
31.
Zurück zum Zitat Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N, et al. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol. 2011 Nov;68(11):1404–11.CrossRefPubMed Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N, et al. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol. 2011 Nov;68(11):1404–11.CrossRefPubMed
32.
Zurück zum Zitat Hooper C, De Souto Barreto P, Payoux P, Salabert AS, Guyonnet S, Andrieu S, et al. Cross-sectional associations of cortical β-amyloid with erythrocyte membrane longchain polyunsaturated fatty acids in older adults with subjective memory complaints. J Neurochem. 2017 May 3; 142, 589–596.CrossRefPubMed Hooper C, De Souto Barreto P, Payoux P, Salabert AS, Guyonnet S, Andrieu S, et al. Cross-sectional associations of cortical β-amyloid with erythrocyte membrane longchain polyunsaturated fatty acids in older adults with subjective memory complaints. J Neurochem. 2017 May 3; 142, 589–596.CrossRefPubMed
33.
Zurück zum Zitat Li D, Mann NJ, Sinclair AJ. A significant inverse relationship between concentrations of plasma homocysteine and phospholipid docosahexaenoic acid in healthy male subjects. Lipids. 2006 Jan;41(1):85–9.CrossRefPubMed Li D, Mann NJ, Sinclair AJ. A significant inverse relationship between concentrations of plasma homocysteine and phospholipid docosahexaenoic acid in healthy male subjects. Lipids. 2006 Jan;41(1):85–9.CrossRefPubMed
34.
Zurück zum Zitat Miller RR, Leanza CM, Phillips EE, Blacquire KD. Homocysteine-induced changes in brain membrane composition correlate with increased brain caspase-3 activities and reduced chick embryo viability. Comp Biochem Physiol B Biochem Mol Biol. 2003 Nov;136(3):521–32.CrossRefPubMed Miller RR, Leanza CM, Phillips EE, Blacquire KD. Homocysteine-induced changes in brain membrane composition correlate with increased brain caspase-3 activities and reduced chick embryo viability. Comp Biochem Physiol B Biochem Mol Biol. 2003 Nov;136(3):521–32.CrossRefPubMed
35.
Zurück zum Zitat van Wijk N, Watkins CJ, Hageman RJJ, Sijben JCW, Kamphuis PGHJ, Wurtman RJ, et al. Combined dietary folate, vitamin B-12, and vitamin B-6 intake influences plasma docosahexaenoic acid concentration in rats. Nutr Metab. 2012 May 30;9(1):49.CrossRef van Wijk N, Watkins CJ, Hageman RJJ, Sijben JCW, Kamphuis PGHJ, Wurtman RJ, et al. Combined dietary folate, vitamin B-12, and vitamin B-6 intake influences plasma docosahexaenoic acid concentration in rats. Nutr Metab. 2012 May 30;9(1):49.CrossRef
Metadaten
Titel
Cross-sectional associations of total plasma homocysteine with cortical β-amyloid independently and as a function of omega 3 polyunsaturated fatty acid status in older adults at risk of dementia
verfasst von
Claudie Hooper
P. de Souto Barreto
N. Coley
E. Caussé
P. Payoux
A. S. Salabert
M. Cesari
S. Andrieu
G.-L. Bowman
M. Weiner
B. Vellas
MAPT/DSA Study Group
Publikationsdatum
02.11.2017
Verlag
Springer Paris
Erschienen in
The journal of nutrition, health & aging / Ausgabe 10/2017
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-017-0989-x

Weitere Artikel der Ausgabe 10/2017

The journal of nutrition, health & aging 10/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.